pharma · T2DM (Type 2 Diabetes Mellitus) · Type 2 Diabetes Mellitus · ORMP
Oramed Pharmaceuticals
ORAMED PHARMACEUTICALS INC.
Oramed Pharmaceuticals patent portfolio — 10 USPTO pharmaceutical patents (A61K/A61P) with grant dates, status, and loss-of-exclusivity filters.
Company details
- Status
- Public
- HQ
- 20 Mamilla Avenue, 3rd Floor, Jerusalem, 9414904, IL
- Founded
- 2006
- Employees
- 16
- Programs
- 14
- Drugs
- 8
- Patents
- 10
Oramed Pharmaceuticals patents
10 pharmaceutical patents indexed for Oramed Pharmaceuticals. 0 expire within 24 months.
Oramed Pharmaceuticals has 10 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 0 expire within 24 months — use filters for patent-cliff planning.
Patent portfolio
-
US 11660327
Methods and compositions for oral administration of proteins
granted -
US 11395848
Methods and compositions for treating diabetes
granted -
US 10967051
Methods and compositions for treating NAFLD, hepatic steatosis, and sequelae thereof
granted -
US 10933022
Protease inhibitor-containing compositions, compositions comprising same, and methods for producing and using same
granted -
US 10881714
Methods and compositions for oral administration of proteins
granted -
US 10398762
Methods and compositions for treating diabetes
granted -
US 10350162
Methods and compositions for oral administration of exenatide
granted -
US 10342764
Protease inhibitor-containing compositions, compositions comprising same, and methods for producing and using same
granted -
US 10058593
Methods and compositions for oral administration of proteins
granted -
US 9259456
Methods and compositions for oral administration of proteins
granted
Frequently asked questions
How many patents does Oramed Pharmaceuticals have?
10 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).
When do Oramed Pharmaceuticals patents expire?
0 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.